Based in Israel, Emedgene is a startup founded in 2017. Brouky records 1 investor associated with the company.
Emedgene provides AI-driven software solutions for genomic data interpretation to assist clinical genetic laboratories in diagnosing genetic disorders more efficiently.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.